Electromed Stock Price, News & Analysis

Electromed, a leader in airway clearance technologies (NYSE American: ELMD), announced the participation of Kathleen Skarvan, President and CEO, and Brad Nagel, CFO, at the Inaugural EF Hutton Global Conference in New York City on May 10-11, 2023. The management team will hold one-on-one meetings on May 11, 2023, providing an opportunity for investors to learn more about Electromed's innovative airway clearance solutions, including the SmartVest® Airway Clearance System. Founded in 1992 and headquartered in New Prague, Minnesota, Electromed focuses on products that assist patients with compromised pulmonary function. For more details, visit www.smartvest.com.

Electromed, Inc. (AMEX: ELMD) will release its fiscal 2023 third quarter financial results on May 9, 2023, after market close. A conference call to discuss the results is set for the same day at 5:00 p.m. Eastern Time. Interested participants can join by calling (888) 999-5318 for domestic or (848) 280-6460 for international lines. The live webcast will be available on Electromed's Investor Relations website. For those unable to join live, a replay will be accessible via phone and online, using the provided links. Electromed specializes in airway clearance technologies, notably the SmartVest® Airway Clearance System, serving patients with compromised pulmonary function.

Electromed (NYSE American: ELMD) reported record net revenue of $11.7 million for Q2 FY 2023, reflecting a 15% increase from $10.2 million in Q2 FY 2022. Homecare revenue grew 14% year-over-year to $10.7 million. Operating income rose to $1.3 million from $1.1 million in Q2 FY 2022, while net income increased to $977,000, or $0.11 per diluted share. Gross profit was $8.68 million, comprising 74% of net revenues, despite rising material and shipping costs. The company reported cash of $6.9 million and ongoing expansion efforts in its sales force and product offerings, including the new SmartVest® Clearway® system.

Electromed, Inc. (AMEX: ELMD) announced that Kathleen Skarvan will retire as President and CEO effective around July 1, 2023. She will transition to a chair role on the board. Skarvan has led the company since 2012, overseeing a tripling of revenues and consistent profitability since 2015. Under her leadership, Electromed executed a strategic growth initiative, enhancing their commercial team and market share. The Board is actively seeking a successor with the help of an executive search firm. Skarvan expressed confidence in the company's future and commitment to ensuring a smooth leadership transition.

Electromed, Inc. (AMEX: ELMD) has announced it will release its financial results for the fiscal 2023 second quarter, which ended December 31, 2022, on February 14, 2023, after the market closes. The company will host a conference call on the same day at 5:00 p.m. Eastern Time to discuss these results. Interested participants can join the call by dialing the provided numbers or accessing the live webcast through Electromed's Investor Relations website. A replay of the call will also be available for those unable to attend live.

Electromed, Inc. (NYSE American: ELMD) announced that it received FDA 510(k) clearance for its SmartVest® Clearway® Airway Clearance System, targeting High Frequency Chest Wall Oscillation (HFCWO) therapy. This modernized device enhances patient experience and outcomes with features like an intuitive touchscreen and lightweight design. The system is crucial for patients with chronic lung conditions, helping to clear mucus and reduce respiratory infections. Limited market release in the U.S. is expected soon.

Electromed, a leader in airway clearance technologies, reported Q1 FY 2023 net revenue of $10.7 million, up 7% year-over-year. Homecare revenue was $9.6 million, a 4% increase. Operating income fell to $44,000 from $538,000 due to supply chain challenges and non-recurring expenses. Net income dropped to $81,000 or $0.01 per diluted share, compared to $439,000 or $0.05 in Q1 FY 2022. The company repurchased $145,000 in stock and had $6.0 million in cash as of September 30, 2022.